TY - JOUR
T1 - Purification, identification, and characterization of two GTP-binding proteins with molecular weights of 25,000 and 21,000 in human platelet cytosol. One is the rap1/smg21/Krev-1 protein and the other is a novel GTP-binding protein
AU - Nagata, K.
AU - Itoh, H.
AU - Katada, T.
AU - Takenaka, K.
AU - Ui, M.
AU - Kaziro, Y.
AU - Nozawa, Y.
PY - 1989
Y1 - 1989
N2 - We have purified, characterized, and identified two GTP-binding proteins with M(r) of 25,000 (c25KG) and 21,000 (c21KG) from the cytosol fraction of human platelets. These two proteins were not copurified with the βγ subunits of heterotrimeric GTP-binding proteins. Amino acid sequences of tryptic fragments of c21KG completely matched with those of rap1 protein (Pizon, V., Chardin, P., Lerosey, L., Olofsson, B., and Tavitian, A. (1988) Oncogene 3, 201-204), smg p21 (Kawata, M., Matsui, Y., Kondo, J., Hishida, T., Teranishi, Y., and Takai, Y. (1988) J. Biol. Chem. 263, 18965-18971), and Krev-1 protein (Kitayama, H., Sugimoto, Y., Matsuzaki, T., Ikawa, Y., and Noda, M. (1989) Cell 56, 77-84). The partial amino acid sequence analysis of c25KG revealed that this protein was different from any low M(r) GTP-binding proteins already reported. c25KG bound about 1 mol of [35S]guanosine 5'-(3-O-thio)triphosphate (GTPγS)/mol of protein, with a K(d) value of about 45 nM. [35S]GTPγS-binding to c25KG was specifically inhibited by guanine nucleotides, GTP and GDP, but not by adenine nucleotides such as ATP and adenyl-5'-yl β,γ-imidodiphosphate. The binding activity was not inhibited by pretreatment with N-ethylmaleimide. c25KG hydrolyzed GTP to librate P(i) with the specific activity of 1.8 mmol of P(i)/mol of protein/min, which are different from the activities of the already purified low M(r) GTP-binding proteins. We conclude that c25KG is a novel GTP-binding protein and c21KG is a rap1/smg p21/Krev-1 product.
AB - We have purified, characterized, and identified two GTP-binding proteins with M(r) of 25,000 (c25KG) and 21,000 (c21KG) from the cytosol fraction of human platelets. These two proteins were not copurified with the βγ subunits of heterotrimeric GTP-binding proteins. Amino acid sequences of tryptic fragments of c21KG completely matched with those of rap1 protein (Pizon, V., Chardin, P., Lerosey, L., Olofsson, B., and Tavitian, A. (1988) Oncogene 3, 201-204), smg p21 (Kawata, M., Matsui, Y., Kondo, J., Hishida, T., Teranishi, Y., and Takai, Y. (1988) J. Biol. Chem. 263, 18965-18971), and Krev-1 protein (Kitayama, H., Sugimoto, Y., Matsuzaki, T., Ikawa, Y., and Noda, M. (1989) Cell 56, 77-84). The partial amino acid sequence analysis of c25KG revealed that this protein was different from any low M(r) GTP-binding proteins already reported. c25KG bound about 1 mol of [35S]guanosine 5'-(3-O-thio)triphosphate (GTPγS)/mol of protein, with a K(d) value of about 45 nM. [35S]GTPγS-binding to c25KG was specifically inhibited by guanine nucleotides, GTP and GDP, but not by adenine nucleotides such as ATP and adenyl-5'-yl β,γ-imidodiphosphate. The binding activity was not inhibited by pretreatment with N-ethylmaleimide. c25KG hydrolyzed GTP to librate P(i) with the specific activity of 1.8 mmol of P(i)/mol of protein/min, which are different from the activities of the already purified low M(r) GTP-binding proteins. We conclude that c25KG is a novel GTP-binding protein and c21KG is a rap1/smg p21/Krev-1 product.
UR - http://www.scopus.com/inward/record.url?scp=0024407607&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0024407607&partnerID=8YFLogxK
M3 - Article
C2 - 2507536
AN - SCOPUS:0024407607
SN - 0021-9258
VL - 264
SP - 17000
EP - 17005
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 29
ER -